Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.99 USD | +3.80% | +12.00% | +6.41% |
04-04 | Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge | MT |
04-04 | Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge | CI |
Sales 2024 * | 1.3B 1.77B | Sales 2025 * | 1.37B 1.88B | Capitalization | 4.62B 6.32B |
---|---|---|---|---|---|
Net income 2024 * | 126M 172M | Net income 2025 * | 158M 216M | EV / Sales 2024 * | 4.03 x |
Net Debt 2024 * | 595M 813M | Net Debt 2025 * | 508M 694M | EV / Sales 2025 * | 3.73 x |
P/E ratio 2024 * |
36.5
x | P/E ratio 2025 * |
27.9
x | Employees | 3,034 |
Yield 2024 * |
2.2% | Yield 2025 * |
2.2% | Free-Float | 99.24% |
Latest transcript on Haemonetics Corporation
1 day | +3.80% | ||
1 week | +12.00% | ||
Current month | +6.61% | ||
1 month | +8.21% | ||
3 months | +11.92% | ||
6 months | +7.62% | ||
Current year | +6.41% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 16-05-15 | |
James D'Arecca
DFI | Director of Finance/CFO | 53 | 22-04-10 |
Jan Hartmann
CTO | Chief Tech/Sci/R&D Officer | - | 06-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Abernathy
BRD | Director/Board Member | 69 | 17-10-17 |
Director/Board Member | 69 | 14-07-22 | |
Ellen Zane
CHM | Chairman | 72 | 18-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.28% | 45 M€ | +0.20% | ||
0.14% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 90.99 | +3.80% | 749,023 |
24-04-25 | 87.66 | +1.67% | 431,158 |
24-04-24 | 86.22 | +1.35% | 238,823 |
24-04-23 | 85.07 | +1.73% | 231,275 |
24-04-22 | 83.62 | +2.93% | 402,130 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.41% | 4.62B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- HAE Stock